MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Search

AtriCure Inc

Fechado

SetorSaúde

39.21 2.24

Visão Geral

Variação de preço das ações

24h

Atual

Mín

37.86

Máximo

39.59

Indicadores-chave

By Trading Economics

Rendimento

5.9M

-267K

Vendas

-1.9M

134M

Margem de lucro

-0.199

Funcionários

1,300

EBITDA

7.3M

8M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+34.9% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

76M

1.9B

Abertura anterior

36.97

Fecho anterior

39.21

Sentimento de Notícias

By Acuity

60%

40%

315 / 360 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

AtriCure Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de jan. de 2026, 23:49 UTC

Grandes Movimentos do Mercado

Karman Space & Defense Shares Rise as 2026 Forecast Tops Analyst Estimates

21 de jan. de 2026, 21:12 UTC

Grandes Movimentos do Mercado

Automaker Stocks Rise After Trump Calls Off European Tariffs

21 de jan. de 2026, 21:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Borse Group to Acquire Allfunds for $6.19 Billion

21 de jan. de 2026, 20:29 UTC

Grandes Movimentos do Mercado

Chip Makers Gain After Trump Calls Off European Tariffs

21 de jan. de 2026, 20:04 UTC

Grandes Movimentos do Mercado

Apparel, Footwear Stocks Rise After Trump Calls Off European Tariffs

21 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise as U.S.-Europe Tensions Ease -- Market Talk

21 de jan. de 2026, 23:34 UTC

Conversa de Mercado

Gold Falls Amid Easing U.S.-Europe Tensions Over Greenland -- Market Talk

21 de jan. de 2026, 22:39 UTC

Ganhos

Schwab's Profit Jumps on Surge in Brokerage Activity -- 2nd Update

21 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

21 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

21 de jan. de 2026, 21:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Tesla Stock In Focus as Musk and Ryanair Chief Trade Insults. Should Investors Worry? -- Barrons.com

21 de jan. de 2026, 21:19 UTC

Ganhos

Charles Schwab Earnings Miss Estimates. The Stock Is Rising Anyway. -- Barrons.com

21 de jan. de 2026, 20:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Borse Group to Acquire Allfunds for $6.19B

21 de jan. de 2026, 20:36 UTC

Conversa de Mercado

U.S. Natural Gas Posts Back-to-Back Hefty Gains -- Market Talk

21 de jan. de 2026, 20:31 UTC

Conversa de Mercado

Oil Settles Higher With Support From Heating Fuel -- Market Talk

21 de jan. de 2026, 20:27 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse Expects Combined Company Will Be Able to Achieve Annual Run Rate Pretax Cost Synergies of About EUR60M

21 de jan. de 2026, 20:27 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 de jan. de 2026, 20:27 UTC

Conversa de Mercado

Was It a 'TACO' Event? -- Market Talk

21 de jan. de 2026, 20:26 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse Has Received Irrevocable Undertakings in Support of Acquisition in Respect of About 48.9% of Allfunds Issued Share Capital Excluding Treasury Shares

21 de jan. de 2026, 20:23 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: Allfunds Stockholders to Receive EUR8.80/Shr, Including Cash, Stock and Permitted Dividend

21 de jan. de 2026, 20:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: Agreement Values Allfunds at About EUR5.3B

21 de jan. de 2026, 20:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse Group Agrees to Buy Allfunds

21 de jan. de 2026, 20:08 UTC

Ganhos

Prologis Revenue Climbs as Warehouse Demand Rebounds -- Update

21 de jan. de 2026, 20:03 UTC

Conversa de Mercado

Precious Metals Drop After Trump Posts About Greenland Deal -- Market Talk

21 de jan. de 2026, 19:51 UTC

Conversa de Mercado

Treasury Markets React to Trump's Softer Tone About Greenland -- Market Talk

21 de jan. de 2026, 19:43 UTC

Conversa de Mercado

U.S. Ethanol Production Expected to Slip -- Market Talk

21 de jan. de 2026, 19:31 UTC

Conversa de Mercado

Gold Settles at Fresh All-Time High -- Market Talk

21 de jan. de 2026, 19:24 UTC

Ganhos

Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. -- Barrons.com

21 de jan. de 2026, 19:10 UTC

Conversa de Mercado

Mexican Inflation Seen Picking Up in Early January -- Market Talk

21 de jan. de 2026, 18:57 UTC

Conversa de Mercado

DAVOS: IBM CEO Krishna Says World Is More Volatile Now -- Market Talk

Comparação entre Pares

Variação de preço

AtriCure Inc Previsão

Preço-alvo

By TipRanks

34.9% parte superior

Previsão para 12 meses

Média 51.83 USD  34.9%

Máximo 64 USD

Mínimo 45 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para AtriCure Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

6

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

30.36 / 33.4Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

315 / 360 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
help-icon Live chat